mesowatch
Early RSO-021 Clinical Trial Provides Hope
divider

Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients

Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients

Mary Pieper

Reading Time: 2 mins

Published On: June 3, 2024

Mary Pieper - author

Mary Pieper is a seasoned journalist, focusing on asbestos awareness and legal and medical issues. She earned her Bachelor's in English with a minor in Journalism from the University of Northern Iowa. Mary's extensive experience includes nearly 20 years as a reporter at the Globe Gazette in Mason City, Iowa, demonstrating her commitment to impactful journalism.

More to Read

divider

September 23, 2024

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

>READ

divider

September 20, 2024

J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement

>READ

divider

September 18, 2024

$39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc

>READ

divider

September 11, 2024

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

>READ

divider

September 10, 2024

J&J Raises Talcum Powder Settlement by Another $1.1 Billion

>READ

divider

August 28, 2024

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

>READ

divider

News & Data

Section divider

FILTER:

Search
Bottom divider
Arizona Veterans: The Persistent Danger of Asbestos Exposure

Arizona Veterans: The Persistent Danger of Asbestos Exposure

John Edwards
7 mins read - September 24, 2024

Awareness

Johnson & Johnson Faces Critical Legal Test in Connecticut

Johnson & Johnson Faces Critical Legal Test in Connecticut

Matthew Davis
5 mins read - September 23, 2024

Settlements

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds

Jared Reagan
10 mins read - September 23, 2024

Awareness


September 11, 2024

Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

>READ

divider

September 10, 2024

J&J Raises Talcum Powder Settlement by Another $1.1 Billion

>READ

divider

August 28, 2024

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

>READ

divider

August 27, 2024

J&J’s Talc Legal Battles: Medical Monitoring and Settlement

>READ

divider

August 26, 2024

The Asbestos Lawsuit Process: From Diagnosis to Legal Action

>READ

divider

August 24, 2024

Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J

>READ

divider

August 22, 2024

GAG-DP Biomaterial Advances Mesothelioma Research

>READ

divider

August 21, 2024

$59.7M Transfer Triggers Legal Battle Over Asbestos Claims

>READ

divider

August 18, 2024

Pleural and Peritoneal Mesothelioma Found in Female Patient

>READ

divider

Browse Categories

divider

Copyright © 2024 by Mesowatch. All Rights Reserved.
The content on this website is protected by law and provided for informational purposes only. It is not intended as a substitute for professional medical or legal advice. Always seek advice from qualified professionals for health or legal matters. Unauthorized use, distribution, or reproduction of this material will be prosecuted. For more information, please review our full disclaimer.DMCA.com Protection Status